Category: Include on Menu
-
BrightView grows sports and golf maintenance portfolio with new projects
BrightView (NYSE:BV) announced an expansion of its sports field and golf course maintenance operations, pointing to a series of recent projects at prominent venues and major sporting events in the United States and abroad. The commercial landscaping provider serves as the Official Field Consultant of Major League Baseball and has supported more than 200 international…
-
Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine
Anavex Life Sciences Corp. (NASDAQ:AVXL) has withdrawn its application for European Union marketing authorization for blarcamesine as an add-on treatment for early Alzheimer’s disease. The decision follows feedback from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) indicating that the application was unlikely to receive a favorable opinion. The biotechnology company…
-
Enliven Therapeutics shares jump 28% after Merck’s $6.7 billion Terns acquisition announcement
Shares of Enliven Therapeutics (NASDAQ:ELVN) climbed 28% on Wednesday following news that Merck (NYSE:MRK) plans to acquire oncology-focused Terns Pharmaceuticals in a $6.7 billion transaction. Maze Therapeutics (NASDAQ:MAZE) also moved higher, rising about 10%. Merck announced Wednesday that it will purchase clinical-stage oncology company Terns Pharmaceuticals for $53.00 per share in cash, valuing the company’s…
-
Beam Therapeutics Shares Climb After Positive BEAM-302 Trial Update
Shares of Beam Therapeutics Inc. (NASDAQ:BEAM) gained about 8% on Wednesday after the company released updated results from its ongoing Phase 1/2 clinical study of BEAM-302, a treatment being developed for alpha-1 antitrypsin deficiency (AATD). According to the company, patients receiving a 60 mg dose of BEAM-302 achieved a mean steady-state total AAT level of…
-
Nanobiotix Shares Surge After Report of Possible Johnson & Johnson Takeover Interest
Shares of Nanobiotix (NASDAQ:NBTX) climbed sharply after media reports suggested that Johnson & Johnson (NYSE:JNJ) is evaluating a potential acquisition of the French biotech firm. According to La Lettre, J&J is reviewing the possibility of buying Nanobiotix, a company it already collaborates with on the development of a cancer treatment. Neither Johnson & Johnson nor…
-
U.S. Import Prices Rise Sharply in February on Higher Fuel Costs
U.S. import prices rose far more than anticipated in February, largely driven by a sharp increase in the cost of fuel imports, according to data released Wednesday by the Labor Department. The report showed import prices climbing 1.3% during the month, following a revised 0.6% increase recorded in January. Economists had projected a more modest…
-
Reports of U.S.-Iran peace proposal may support Wall Street at the open: Dow Jones, S&P, Nasdaq, Futures
U.S. stock futures were pointing to a stronger start on Wednesday, suggesting equities could rebound after the modest pullback seen in the previous trading session. Oil prices have retreated following a report from the New York Times stating that the United States has delivered a 15-point proposal to Iran aimed at ending the war in…
-
Lockheed Martin to ramp up Precision Strike Missile production under new framework deal
Lockheed Martin (NYSE:LMT) announced a framework agreement with the Department of War aimed at accelerating the production of Precision Strike Missiles (PrSM), with plans to expand manufacturing capacity fourfold. The arrangement builds on a $4.94 billion contract awarded by the U.S. Army last year. The framework includes the possibility of a multi-year contract lasting up…
-
Waterdrop shares climb more than 3% after strong Q4 results and AI-driven growth
Waterdrop Inc. (NYSE:WDH) reported fourth-quarter results that came in above market expectations. The company’s shares rose about 3.59% in after-hours trading following the earnings release. The insurance and healthcare technology platform posted adjusted earnings per share of $0.01 for the quarter, while revenue totaled $201.8 million, representing a 105.5% year-over-year increase from $686.8 million in…
-
On Holding shares drop 5% as CEO Martin Hoffmann announces departure
On Holding AG (NYSE:ONON) shares declined about 5% on Wednesday after the company revealed that Chief Executive Officer Martin Hoffmann will step down after 13 years with the Swiss sportswear company. Starting May 1, company co-founders David Allemann and Caspar Coppetti will take on the roles of Co-CEOs while continuing to serve as Executive Co-Chairmen…